Tag: Patents
Standard-Essential Patents and Antitrust: Of Fighting Ships and Frankenstein Monsters
Sean P. Gates, Oct 15, 2013
Standard-essential patents (“SEPs”) have been at the heart of a debate about the reach of U.S. antitrust ...
When Does Interpretation Become Rewriting? The FTC Runs With the Actavis...
Kent Bernard, Sep 30, 2013
A Hatch-Waxman settlement case finally reached the Supreme Court, and when it did the Court in FTC v. Actavis rejected both...
Injunctions And Standard Essential Patents (SEPs): The Problems Of Arguing From...
Robert O'Donoghue, May 23, 2013
CPI Europe Column edited by Anna Tzanaki (Competition Policy International) presents:
Injunctions And Standard Essential Patents (SEPs): The Problems Of Arguing...
Innovation is King. Or is it?
David Cardwell, Paul Lugard, Oct 05, 2012
Nowadays, it is undisputed that innovation is a key driver of consumer welfare. As a result, unwarranted restraints...
Innovation is King. Or is it?
David Cardwell, Paul Lugard, Oct 05, 2012
Nowadays, it is undisputed that innovation is a key driver of consumer welfare. As a result, unwarranted restraints...
Has the Administrative Court’s Reversal of the IAA Decision in Pfizer...
Daniela Ampollini, Oct 15, 2012
In my article, Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case, which appeared in...
Looking for Sense in the Italian Antitrust Authority Decision in the...
Daniela Ampollini, Jul 27, 2012
The January 2012 decision of the Italian Antitrust Authority ("IAA") in the Pfizer case, involving Pfizer's actions to counter the marketing...
European Commission Enforcement in the Pharmaceutical Sector: Less Than Expected? The...
Sean-Paul Brankin, Jul 27, 2012
On July 6, 2011, the European Commission closed the case file in itsBoehringer/Almirall investigation. It did so without a formal...
Cervantes Sequel: The FTC’s Quest to End Pay-for-Delay Pharma Settlements
Anne Layne-Farrar, Jun 27, 2012
We are drawing close to the thirtieth anniversary of the Drug Price Competition and Patent Term Restoration Act, better known...
Federal Trade Commission Rejected in “Reverse Payment” Suit
Kevin Noonan, Jun 27, 2012
The Federal Trade Commission in recent years has identified a practice it considers to be a threat to consumers regarding...
